BioForce Nanosciences Holdings, Inc. BFNH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 238.70K | -102.40K | -118.60K | -115.90K | -122.80K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -248.80K | -- | 800.00 | 0.00 | 0.00 |
| Change in Net Operating Assets | -16.90K | 109.50K | 106.90K | 104.80K | 94.90K |
| Cash from Operations | -27.00K | 7.10K | -10.90K | -11.10K | -27.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 17.40K | -- | 10.90K | 11.00K | 15.00K |
| Total Debt Repaid | 1.50K | -1.50K | -- | -- | -- |
| Issuance of Common Stock | 2.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.90K | -1.50K | 10.90K | 11.00K | 15.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.00K | 5.60K | 0.00 | -100.00 | -12.90K |